Volume | 762,109 |
|
|||||
News | - | ||||||
Day High | 12.65 | Low High |
|||||
Day Low | 12.01 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
NovoCure Ltd | NVCR | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
12.15 | 12.01 | 12.65 | 12.635 | 12.23 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
12,518 | 762,109 | $ 12.45 | $ 9,486,763 | - | 10.87 - 83.60 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:50:08 | 2 | $ 12.50 | USD |
NovoCure Ltd Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.35B | 107.09M | - | 509.34M | -207.04M | -1.93 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
NovoCure News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NVCR Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 11.89 | 12.65 | 11.70 | 12.14 | 993,266 | 0.66 | 5.55% |
1 Month | 15.63 | 15.63 | 11.70 | 13.42 | 1,140,066 | -3.08 | -19.71% |
3 Months | 14.35 | 18.04 | 11.70 | 14.56 | 1,299,144 | -1.80 | -12.54% |
6 Months | 14.48 | 18.04 | 10.87 | 13.88 | 1,366,723 | -1.93 | -13.33% |
1 Year | 61.12 | 83.60 | 10.87 | 25.01 | 1,519,459 | -48.57 | -79.47% |
3 Years | 208.82 | 232.76 | 10.87 | 60.70 | 944,549 | -196.27 | -93.99% |
5 Years | 45.12 | 232.76 | 10.87 | 76.38 | 934,515 | -32.57 | -72.19% |
NovoCure Description
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves commercial-stage oncology operations involving therapies to cure critical tumors. Its pipeline consists of Ovarian Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, and Brain Metastasis. NovoCure derives its major revenues in the United States. |